Acalabrutinib
Back to search| Scientific Name: | Acalabrutinib |
| Brand Name: | Calquence |
| Company Owner: | Not Available |
| Mechanism Of Action | Mantle Cell Lymphoma (MCL) is a rare yet aggressive type of B-cell non-Hodgkin lymphoma (NHL) with poor prognosis |
| Description of the Drug: | Acalabrutinib is a Bruton tyrosine kinase inhibitor used to treat mantle cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB11703
